Patient Group AMD Alliance International Responds To CATT Trials Research
Results of the Comparison of AMD Treatments Trials (CATT) study were published online today in The New England Journal of Medicine (NEJM). The CATT study was designed to compare two drugs currently used to treat wet-AMD: Lucentis (ranibizumab) and Avastin (bevacizumab) -- a drug that is used off label for ocular use in a number of countries around the world...